Naomi M Hamburg MD
Vascular Medicine
Associate Professor, Medicine, Boston University School of Medicine
Join to View Full Profile
732 Harrison AvePreston, 3rd FloorBoston, MA 02118
Phone+1 617-638-7490
Fax+1 617-414-8742
Dr. Hamburg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston University Medical CenterFellowship, Cardiovascular Disease, 2003 - 2007
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2000 - 2003
Harvard Medical SchoolClass of 2000
Certifications & Licensure
MA State Medical License 2006 - 2026
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Effects of TUDCA on Endothelial Function in Type 2 DM Start of enrollment: 2018 Apr 02
- Effects of Nitric Oxide on the Endothelium During Hemolysis. Start of enrollment: 2018 Dec 05
- Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes Start of enrollment: 2022 May 31
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsVascular dysfunction in diabetes and pharmacotherapeutic opportunities: a focus on endothelial cell health.Ross A Okazaki, Syed H Rizvi, Rachael Lyons, Leili Behrooz, Naomi M Hamburg
American Journal of Physiology. Heart and Circulatory Physiology. 2025-09-01 - Novel microRNA pathways of impaired angiogenesis in human peripheral artery disease adipose tissue.Ross A Okazaki, Syed Hm Rizvi, Rosa Bretón-Romero, Yuxiang Zhou, Robert M Weisbrod
Vascular Medicine. 2025-08-25 - Cardiovascular Health Effects and Synthetic Cooling Agents in E-Cigarettes Labeled as "Clear" Marketed in Massachusetts After the Tobacco Product Flavoring Ban.Erika T Minetti, Hanno C Erythropel, Rachel Keith, Danielle R Davis, Julie B Zimmerman
Journal of the American Heart Association. 2025-08-19
Lectures
- ARS Debate Post Question Who Should Have ABI?2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- ARS Debate Post Question Who Should Have ABI?2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Ambulation to Rivaroxaban: Branching Outside the Coronaries2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Join now to see all
Press Mentions
Leg Artery Disease Can Lead to Amputation, but a Surgery May Help Prevent ThatNovember 9th, 2022- November 2021 Faculty Appointments, Promotions AnnouncedNovember 9th, 2021
- Vaping Combined with Smoking Is Likely as Harmful as Smoking Cigarettes Alone, Study FindsJanuary 4th, 2021
- Join now to see all
Grant Support
- Endothelial Cell Health Across the Spectrum of Cardiometabolic DiseaseBOSTON UNIVERSITY MEDICAL CAMPUS2023–2028
- Endothelial Cell Health Across the Spectrum of Cardiometabolic DiseaseBOSTON UNIVERSITY MEDICAL CAMPUS2023–2028
- Endothelial Cell Health Across the Spectrum of Cardiometabolic DiseaseBOSTON UNIVERSITY MEDICAL CAMPUS2023–2028
- Utilization of BioDot Omnia Automated Liquid Dispensing/Handling System to Enhance the Efficiency and Accuracy of High Throughput Biological AssaysBOSTON MEDICAL CENTER2025–2026
- Long-Term Endothelial Effects of COVID-19 in ObesityBETH ISRAEL DEACONESS MEDICAL CENTER2022–2026
- Microrna Profile In Peripheral Artery DiseaseNational Heart, Lung, And Blood Institute2012
- Endothelial Insulin Resistance, Inflammation And Vascular Function In DiabetesNational Heart, Lung, And Blood Institute2010–2012
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
